111 (NASDAQ:YI) Trading Down 1.1% – Here’s Why

111, Inc. Sponsored ADR (NASDAQ:YI)’s share price traded down 1.1% during mid-day trading on Wednesday . The stock traded as low as $3.49 and last traded at $3.51. 5,615 shares traded hands during mid-day trading, an increase of 92% from the average daily volume of 2,926 shares. The stock had previously closed at $3.55.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Sell rating, According to MarketBeat, 111 presently has a consensus rating of “Sell”.

111 Price Performance

The company has a fifty day simple moving average of $3.93 and a two-hundred day simple moving average of $5.64. The company has a market capitalization of $31.36 million, a P/E ratio of -2.55 and a beta of 0.67.

Insiders Place Their Bets

In other 111 news, Director Jian David Sun sold 115,440 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80. Following the completion of the transaction, the director owned 583,111 shares of the company’s stock, valued at $128,284.42. The trade was a 16.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 595,540 shares of company stock worth $141,105. 43.90% of the stock is owned by insiders.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.